Since my sell rating earlier this year, Astera Labs stock has plunged by nearly 50%. Read why I now upgrade ALAB from sell to ...

Our fair value estimate for CRBM is HKD 1.50 per share, implying a price/book ratio of 0.2 times and an enterprise value/adjusted EBITDA of 5.2 times as per our 2025 estimates. Our fair value estimate ...

We recently published a list of Top 10 Stocks to Buy According to Adage Capital Management. In this article, we are going to ...

When consumer product companies focus on more than raw sales, they can better prioritize SKUs and make data-driven business ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

DaVita has experienced difficulty enrolling more patients in its dialysis program, reporting a decline in its patients since ...

Gross margin has trended down over the last decade ... We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our ...

InvestingPro analysis reveals that 14 analysts have ... Analysts highlight a significant miss in product gross margins, which declined by 1,000 basis points over the past year.

Gross margin: Reached a record 50.6% ... driven by continued innovation and market expansion. For detailed analysis and growth projections, investors can access Henkel’s comprehensive Pro ...

We recently published a list of Top 10 Stocks to Buy According to Adage Capital Management. In this article, we are going to ...

Full Year 2024 Financial Results Revenue for full year 2024 was $79.9 million, a decrease of 1% compared to full year 2023. Surgical Glaucoma revenue was $75.9 million for full year 2024, an increase ...

Delivered Net Sales at High End of Guidance RangeDrove 10% Year-Over-Year Total Order Growth in Q4 2024Exceeded Profitability Expectations and ...